Overview

As a board cerified radiation oncologist, Jeffrey D. Bradley, MD, FACR, FASTRO, specializes in thoracic malignancies with a focus on stereotactic body radiation therapy and proton beam therapy. He is principal investigator of a number of transformational clinical trials for lung cancer patients.

Prior to Emory, Dr. Bradley was at Washington University School of Medicine in St. Louis where he was the S. Lee Kling Endowed Professor of Radiation Oncology, clinical director of the Kling Proton Center, and chief of the Radiation Oncology Thoracic Cancer Service. At Barnes Jewish in St Louis, he led the development of the first single room proton center in the world.

Dr. Bradley is Lung Cancer Committee Chair at NRG Oncology, the largest of the four adult National Clinical Trials Network Groups supported by the National Cancer Institute. He was named a fellow of the American Society for Radiation Oncology (ASTRO) in 2017. He served as chair of the lung/sarcoma section of oral boards with the American Board of Radiology for 10 years. He is also a founding member of the Particle Therapy Oncology Group of North America.

Dr. Bradley also holds professional memberships with American Society for Radiation Oncology, American Society for Clinical Oncology, and International Association for the Study of Lung Cancer.

Academic Appointment

Education

Research